Primary care system factors and clinical decision-making in patients that could have lung cancer: A vignette study in five balkan region countries

1Gatta G, Mallone S, van der Zwan JM, Trama A, Siesling S, Capocaccia R, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol. 2014;15:23–34. doi: 10.1016/S1470-2045(13)70546-1. Gatta G Mallone S van der Zwan JM Trama A Siesling S Capocaccia R et al Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study Lancet Oncol 20141523 34 doi 10.1016/S1470-2045(13)70546-1Open DOISearch in Google Scholar

2Carter JL, Coletti RJ, Harris RP. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ. 2015;350. doi: 10.1136/bmj.g7773. Carter JL Coletti RJ Harris RP Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods BMJ 2015350 doi 10.1136/bmj.g7773433226325569206Open DOISearch in Google Scholar

3Zahl PH, Jørgensen KJ, Gøtzsche PC. Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis. Br J Cancer. 2013;109:2014–9. doi: 10.1038/bjc.2013.427. Zahl PH Jørgensen KJ Gøtzsche PC Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis Br J Cancer 20131092014 9 doi 10.1038/bjc.2013.427379015223963144Open DOISearch in Google Scholar

4Richards MA. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer. 2009;101:S125–9. doi: 10.1038/sj.bjc.6605402. Richards MA The size of the prize for earlier diagnosis of cancer in England Br J Cancer 2009101S125 9 doi 10.1038/sj.bjc.6605402279071519956156Open DOISearch in Google Scholar

5Woods LM, Coleman MP, Lawrence G, Rashbass J, Berrino F, Rachet B. Evidence against the proposition that “UK cancer survival statistics are misleading”: simulation study with National Cancer Registry data. BMJ. 2011;342. doi: 10.1136/bmj.d3399. Woods LM Coleman MP Lawrence G Rashbass J Berrino F Rachet B Evidence against the proposition that “UK cancer survival statistics are misleading”: simulation study with National Cancer Registry data BMJ 2011342 doi 10.1136/bmj.d3399311148321659366Open DOISearch in Google Scholar

6Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020;371:m4087. doi: 10.1136/bmj.m4087. Hanna TP King WD Thibodeau S Jalink M Paulin GA Harvey-Jones E et al Mortality due to cancer treatment delay: systematic review and meta-analysis BMJ 2020371m4087 doi 10.1136/bmj.m4087761002133148535Open DOISearch in Google Scholar

7Tørring ML, Frydenberg M, Hansen RP, Olesen F, Vedsted P. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur J Cancer. 2013;49:2187– 98. doi: 10.1016/j.ejca.2013.01.025. Tørring ML Frydenberg M Hansen RP Olesen F Vedsted P Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care Eur J Cancer 2013492187 98 doi 10.1016/j.ejca.2013.01.02523453935Open DOISearch in Google Scholar

8Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112:S92–107. doi: 10.1038/bjc.2015.48. Neal RD Tharmanathan P France B Din NU Cotton S Fallon-Ferguson J et al Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review Br J Cancer 2015112S92 107 doi 10.1038/bjc.2015.48438598225734382Open DOISearch in Google Scholar

9Butler J, Foot C, Bomb M, Hiom S, Coleman M, Bryant H, et al. The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom. Health Policy (New York). 2013;112(1–2):148–55. doi: 10.1016/j.healthpol.2013.03.021. Butler J Foot C Bomb M Hiom S Coleman M Bryant H et al The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom Health Policy (New York) 20131121–2148 55 doi 10.1016/j.healthpol.2013.03.02123693117Open DOISearch in Google Scholar

10Jacobsen MM, Silverstein SC, Quinn M, Waterston LB, Thomas CA, Benneyan JC, et al. Timeliness of access to lung cancer diagnosis and treatment: a scoping literature review. Lung Cancer. 2017;112:156–64. doi: 10.1016/j.lungcan.2017.08.011. Jacobsen MM Silverstein SC Quinn M Waterston LB Thomas CA Benneyan JC et al Timeliness of access to lung cancer diagnosis and treatment: a scoping literature review Lung Cancer 2017112156 64 doi 10.1016/j.lungcan.2017.08.01129191588Open DOISearch in Google Scholar

11Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi: 10.3322/caac.21492. Bray F Ferlay J Soerjomataram I Siegel RL Torre LA Jemal A. Global cancer statistics 2018 GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 201868394 424 doi 10.3322/caac.21492Open DOISearch in Google Scholar

12Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–75. doi: 10.1016/S0140-6736(17)33326-3. Allemani C Matsuda T Di Carlo V Harewood R Matz M Nikšić M et al Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries Lancet 20183911023 75 doi 10.1016/S0140-6736(17)33326-3Open DOISearch in Google Scholar

13Zadnik V, Žagar T, Primic Žakelj M. Cancer patients’ survival: standard calculation methods and some considerations regarding their interpretation. Zdr Varst. 2016;55:144–51. doi: 10.1515/sjph-2016-0012. Zadnik V Žagar T Primic Žakelj M Cancer patients’ survival: standard calculation methods and some considerations regarding their interpretation Zdr Varst 201655144 51 doi 10.1515/sjph-2016-0012Open DOISearch in Google Scholar

14Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, et al. The expanding role of primary care in cancer control. Lancet Oncol. 2015;16:1231–72. doi: 10.1016/S1470-2045(15)00205-3. Rubin G Berendsen A Crawford SM Dommett R Earle C Emery J et al The expanding role of primary care in cancer control Lancet Oncol 2015161231 72 doi 10.1016/S1470-2045(15)00205-3Open DOISearch in Google Scholar

15de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503–13. doi: 10.1056/nejmoa1911793. de Koning HJ van der Aalst CM de Jong PA Scholten ET Nackaerts K Heuvelmans MA et al Reduced lung-cancer mortality with volume CT screening in a randomized trial N Engl J Med 20203826503 13 doi 10.1056/nejmoa1911793Open DOISearch in Google Scholar

16Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. doi: 10.1056/nejmoa1102873. Aberle DR Adams AM Berg CD Black WC Clapp JD Fagerstrom RM et al Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 20113655395 409 doi 10.1056/nejmoa1102873Open DOISearch in Google Scholar

17Harris M, Taylor G. How health system factors affect primary care practitioners’ decisions to refer patients for further investigation: protocol for a pan-European ecological study. BMC Health Serv Res. 2018;18:338. doi: 10.1186/s12913-018-3170-2. Harris M Taylor G How health system factors affect primary care practitioners’ decisions to refer patients for further investigation: protocol for a pan-European ecological study BMC Health Serv Res 201818338 doi 10.1186/s12913-018-3170-2594133329739409Open DOISearch in Google Scholar

18Rose PW, Rubin G, Perera-Salazar R, Almberg SS, Barisic A, Dawes M, et al. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey. BMJ Open. 2015;5:e007212. doi: 10.1136/ bmjopen-2014-007212. Rose PW Rubin G Perera-Salazar R Almberg SS Barisic A Dawes M et al Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey BMJ Open 20155e007212 doi 10.1136/bmjopen-2014-007212445274826017370Open DOISearch in Google Scholar

19Starfield B, Shi L, Macinko J. Contribution of primary care to health systems and health. Milbank Q. 2005;83:457–502. doi: 10.1111/j.1468-0009.2005.00409.x. Starfield B Shi L Macinko J Contribution of primary care to health systems and health Milbank Q 200583457 502 doi 10.1111/j.1468-0009.2005.00409.x269014516202000Open DOISearch in Google Scholar

20Vedsted P, Olesen F. Are the serious problems in cancer survival partly rooted in gatekeeper principles? An ecologic study. Br J Gen Pract. 2011;61:e508-12. doi: 10.3399/bjgp11X588484. Vedsted P Olesen F Are the serious problems in cancer survival partly rooted in gatekeeper principles? An ecologic study Br J Gen Pract 201161e508 12 doi 10.3399/bjgp11X588484314553521801563Open DOISearch in Google Scholar

21Olesen F, Hansen RP, Vedsted P. Delay in diagnosis: the experience in Denmark. Br J Cancer. 2009;101:S5–8. doi: 10.1038/sj.bjc.6605383. Olesen F Hansen RP Vedsted P Delay in diagnosis: the experience in Denmark Br J Cancer 2009101S5 8 doi 10.1038/sj.bjc.6605383Open DOISearch in Google Scholar

22Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the international cancer benchmarking partnership): an analysis of population-based cancer registry data. Lancet. 2011;377:127–38. doi: 10.1016/S0140-6736(10)62231-3. Coleman MP Forman D Bryant H Butler J Rachet B Maringe C et al Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the international cancer benchmarking partnership): an analysis of population-based cancer registry data Lancet 2011377127 38 doi 10.1016/S0140-6736(10)62231-3Open DOISearch in Google Scholar

23Harris M, Frey P, Esteva M, Gašparović Babić S, Marzo-Castillejo M, Petek D, et al. How the probability of presentation to a primary care clinician correlates with cancer survival rates: an European survey using vignettes. Scand J Prim Health Care. 2017;35:27–34. doi: 10.1080/02813432.2017.1288692. Harris M Frey P Esteva M Gašparović Babić S Marzo-Castillejo M Petek D et al How the probability of presentation to a primary care clinician correlates with cancer survival rates: an European survey using vignettes Scand J Prim Health Care 20173527 34 doi 10.1080/02813432.2017.1288692Open DOISearch in Google Scholar

24Prades J, Espinás JA, Font R, Argimon JM, Borrs JM. Implementing a Cancer Fast-track Programme between primary and specialised care in Catalonia (Spain): a mixed methods study. Br J Cancer. 2011;105:753–9. doi: 10.1038/bjc.2011.308. Prades J Espinás JA Font R Argimon JM Borrs JM Implementing a Cancer Fast-track Programme between primary and specialised care in Catalonia (Spain): a mixed methods study Br J Cancer 2011105753 9 doi 10.1038/bjc.2011.308Open DOISearch in Google Scholar

25Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians - a national Danish project. Health Policy (New York). 2012;105:65–70. doi: 10.1016/j.healthpol.2011.11.001. Probst HB Hussain ZB Andersen O Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians - a national Danish project Health Policy (New York) 201210565 70 doi 10.1016/j.healthpol.2011.11.001Open DOISearch in Google Scholar

26Department of Health. The NHS Cancer Plan. Dep Heal. 2000:1–98. Accessed 3rd November, 2020 at: http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4014513.pdf Department of Health The NHS Cancer Plan. Dep Heal 20001 98 Accessed 3rd November, 2020 at: http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4014513.pdfSearch in Google Scholar

27Christensen ED, Harvald T, Jendresen M, Aggestrup S, Petterson G. The impact of delayed diagnosis of lung cancer on the stage at the time of operation. Eur J Cardio-thoracic Surg. 1997;12:880–4. doi: 10.1016/S1010-7940(97)00275-3. Christensen ED Harvald T Jendresen M Aggestrup S Petterson G The impact of delayed diagnosis of lung cancer on the stage at the time of operation Eur J Cardio-thoracic Surg 199712880 4 doi 10.1016/S1010-7940(97)00275-3Open DOISearch in Google Scholar

28Lo DS, Zeldin RA, Skrastins R, Fraser IM, Newman H, Monavvari A, et al. Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis. J Thorac Oncol. 2007;2:1001–6. doi: 10.1097/JTO.0b013e318158d4b6. Lo DS Zeldin RA Skrastins R Fraser IM Newman H Monavvari A et al Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis J Thorac Oncol 200721001 6 doi 10.1097/JTO.0b013e318158d4b617975490Open DOISearch in Google Scholar

29Nicholson BD, Oke JL, Rose PW, Mant D. Variation in direct access to tests to investigate cancer: a survey of english general practitioners. PLoS One. 2016;11: e0159725. doi: 10.1371/journal.pone.0159725. Nicholson BD Oke JL Rose PW Mant D Variation in direct access to tests to investigate cancer: a survey of english general practitioners PLoS One 201611 e0159725 doi 10.1371/journal.pone.0159725495780427447931Open DOISearch in Google Scholar

30Sahota IS, Kostaras X, Hagen NA. Improving access to cancer guidelines: feedback from health care professionals. Curr Oncol. 2015;22:392–8. doi: 10.3747/co.22.2704. Sahota IS Kostaras X Hagen NA Improving access to cancer guidelines: feedback from health care professionals Curr Oncol 201522392 8 doi 10.3747/co.22.2704468765926715871Open DOISearch in Google Scholar

31Hansen RP, Vedsted P, Sokolowski I, Søndergaard J, Olesen F. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 2011;11:284. doi: 10.1186/1472-6963-11-284. Hansen RP Vedsted P Sokolowski I Søndergaard J Olesen F Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients BMC Health Serv Res 201111284 doi 10.1186/1472-6963-11-284321788722027084Open DOISearch in Google Scholar

32Maclean R, Jeffreys M, Ives A, Jones T, Verne J, Ben-Shlomo Y. Primary care characteristics and stage of cancer at diagnosis using data from the national cancer registration service, quality outcomes framework and general practice information. BMC Cancer. 2015;15:500. doi: 10.1186/s12885-015-1497-1. Maclean R Jeffreys M Ives A Jones T Verne J Ben-Shlomo Y Primary care characteristics and stage of cancer at diagnosis using data from the national cancer registration service, quality outcomes framework and general practice information BMC Cancer 201515500 doi 10.1186/s12885-015-1497-1449121726141458Open DOISearch in Google Scholar

33Hansen RP, Vedsted P, Sokolowski I, Søndergaard J, Olesen F. General practitioner characteristics and delay in cancer diagnosis: a population-based cohort study. BMC Fam Pract. 2011;12:100. doi: 10.1186/1471-2296-12-100. Hansen RP Vedsted P Sokolowski I Søndergaard J Olesen F General practitioner characteristics and delay in cancer diagnosis: a population-based cohort study BMC Fam Pract 201112100 doi 10.1186/1471-2296-12-100319146821943310Open DOISearch in Google Scholar

34Aldridge S, The Strategy Unit. Early diagnosis of cancer: evidence review. 2020. Accessed 23rd August, 2021 at: https://www.strategyunitwm.nhs.uk/sites/default/files/2021-04/20210407Earlydiagnosis of cancer_FINAL_0.pdf. Aldridge S The Strategy Unit. Early diagnosis of cancer: evidence review 2020 Accessed 23rd August, 2021 at https://www.strategyunitwm.nhs.uk/sites/default/files/2021-04/20210407Earlydiagnosisofcancer_FINAL_0.pdfSearch in Google Scholar

35Evans SC, Roberts MC, Keeley JW, Blossom JB, Amaro CM, Garcia AM, et al. Vignette methodologies for studying clinicians’ decision-making: validity, utility, and application in ICD-11 field studies. Int J Clin Heal Psychol. 2015;15:160–70. doi: 10.1016/j.ijchp.2014.12.001. Evans SC Roberts MC Keeley JW Blossom JB Amaro CM Garcia AM et al Vignette methodologies for studying clinicians’ decision-making: validity, utility, and application in ICD-11 field studies Int J Clin Heal Psychol 201515160 70 doi 10.1016/j.ijchp.2014.12.001622468230487833Open DOISearch in Google Scholar

36Hrisos S, Eccles MP, Francis JJ, Dickinson HO, Kaner EF, Beyer F, et al. Are there valid proxy measures of clinical behaviour? A systematic review. Implement Sci. 2009;4. doi: 10.1186/1748-5908-4-37. Hrisos S Eccles MP Francis JJ Dickinson HO Kaner EF Beyer F et al Are there valid proxy measures of clinical behaviour? A systematic review Implement Sci 20094 doi 10.1186/1748-5908-4-37271319419575790Open DOISearch in Google Scholar

37Bradley SH, Grice A, Neal RD, Abraham S, Rodriguez Lopez R, Shinkins B, et al. Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review. Br J Gen Pract. 2019;69:E827–35. doi: 10.3399/bjgp19X706853. Bradley SH Grice A Neal RD Abraham S Rodriguez Lopez R Shinkins B et al Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review Br J Gen Pract 201969E827 35 doi 10.3399/bjgp19X706853680516431636130Open DOISearch in Google Scholar

38Stapley S, Sharp D, Hamilton W. Negative chest X-rays in primary care patients with lung cancer. Br J Gen Pract. 2006;56:570–3. Stapley S Sharp D Hamilton W Negative chest X-rays in primary care patients with lung cancer Br J Gen Pract 200656570 3Search in Google Scholar

39Kennedy MPT, Cheyne L, Darby M, Plant P, Milton R, Robson JM, et al. Lung cancer stage-shift following a symptom awareness campaign. Thorax. 2018;73:1128–36. doi: 10.1136/thoraxjnl-2018-211842. Kennedy MPT Cheyne L Darby M Plant P Milton R Robson JM et al Lung cancer stage-shift following a symptom awareness campaign Thorax 2018731128 36 doi 10.1136/thoraxjnl-2018-21184229950525Open DOISearch in Google Scholar

40Bradley SH, Kennedy MPT, Neal RD. Recognising lung cancer in primary care. Adv Ther. 2019;36:19–30. doi: 10.1007/s12325-018-0843-5. Bradley SH Kennedy MPT Neal RD Recognising lung cancer in primary care Adv Ther 20193619 30 doi 10.1007/s12325-018-0843-5631824030499068Open DOISearch in Google Scholar

41Rubin GP, Saunders CL, Abel GA, Mcphail S, Lyratzopoulos G, Neal RD. Impact of investigations in general practice on timeliness of referral for patients subsequently diagnosed with cancer: analysis of national primary care audit data. Br J Cancer. 2015;112:676–87. doi: 10.1038/ bjc.2014.634. Rubin GP Saunders CL Abel GA Mcphail S Lyratzopoulos G Neal RD Impact of investigations in general practice on timeliness of referral for patients subsequently diagnosed with cancer: analysis of national primary care audit data Br J Cancer 2015112676 87 doi 10.1038/bjc.2014.634433349225602963Open DOISearch in Google Scholar

42Neal RD, Din NU, Hamilton W, Ukoumunne OC, Carter B, Stapley S, et al. Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database. Br J Cancer. 2014;110:584–92. doi: 10.1038/bjc.2013.791. Neal RD Din NU Hamilton W Ukoumunne OC Carter B Stapley S et al Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database Br J Cancer 2014110584 92 doi 10.1038/bjc.2013.791391513924366304Open DOISearch in Google Scholar